EXCLUSIVE LICENSE AGREEMENT by and between EISAI CO. LTD. and PHARMAVANT 7 GmbH dated as of November 24, 2021Exclusive License Agreement • February 14th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
This EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of November 24, 2021 (the “Effective Date”) by and between Eisai Co. Ltd., a Japanese corporation with offices at [***] (“Eisai”), and Pharmavant 7 GmbH, a company organized under the laws of Switzerland and having an address of [***] (“Pharmavant”) . For purposes of this Agreement, Eisai and Pharmavant are each referred to herein by name, individually as a “Party” or, collectively, as the “Parties.”
